JBG SMITH PROPERTIES (JBGS)

US46590V1008 - REIT

18.39  -0.06 (-0.33%)

After market: 18.39 0 (0%)

Fundamental Rating

2

Taking everything into account, JBGS scores 2 out of 10 in our fundamental rating. JBGS was compared to 127 industry peers in the Diversified REITs industry. The financial health of JBGS is average, but there are quite some concerns on its profitability. JBGS has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

JBGS had negative earnings in the past year.
In the past year JBGS had a positive cash flow from operations.
In multiple years JBGS reported negative net income over the last 5 years.
In the past 5 years JBGS always reported a positive cash flow from operatings.

1.2 Ratios

JBGS's Return On Assets of -2.81% is on the low side compared to the rest of the industry. JBGS is outperformed by 82.40% of its industry peers.
JBGS's Return On Equity of -7.41% is on the low side compared to the rest of the industry. JBGS is outperformed by 74.40% of its industry peers.
JBGS has a worse Return On Invested Capital (0.37%) than 89.60% of its industry peers.
Industry RankSector Rank
ROA -2.81%
ROE -7.41%
ROIC 0.37%
ROA(3y)-0.45%
ROA(5y)-0.28%
ROE(3y)-1.13%
ROE(5y)-0.71%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JBGS has a worse Operating Margin (4.12%) than 89.60% of its industry peers.
JBGS's Operating Margin has been stable in the last couple of years.
JBGS has a worse Gross Margin (50.96%) than 80.00% of its industry peers.
JBGS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.12%
PM (TTM) N/A
GM 50.96%
OM growth 3YN/A
OM growth 5Y-1.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.85%
GM growth 5Y-0.05%

4

2. Health

2.1 Basic Checks

JBGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, JBGS has less shares outstanding
Compared to 5 years ago, JBGS has less shares outstanding
The debt/assets ratio for JBGS is higher compared to a year ago.

2.2 Solvency

JBGS has an Altman-Z score of 0.23. This is a bad value and indicates that JBGS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.23, JBGS is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
JBGS has a Debt/Equity ratio of 1.30. This is a high value indicating a heavy dependency on external financing.
JBGS has a Debt to Equity ratio (1.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACC0.07
WACC5.57%

2.3 Liquidity

A Current Ratio of 2.26 indicates that JBGS has no problem at all paying its short term obligations.
The Current ratio of JBGS (2.26) is better than 80.00% of its industry peers.
A Quick Ratio of 2.26 indicates that JBGS has no problem at all paying its short term obligations.
The Quick ratio of JBGS (2.26) is better than 81.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.26

1

3. Growth

3.1 Past

The earnings per share for JBGS have decreased strongly by -2620.00% in the last year.
JBGS shows a decrease in Revenue. In the last year, the revenue decreased by -3.93%.
JBGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.27% yearly.
EPS 1Y (TTM)-2620%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-370%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y0.08%
Revenue growth 5Y-1.27%
Sales Q2Q%-6.68%

3.2 Future

Based on estimates for the next years, JBGS will show a very negative growth in Earnings Per Share. The EPS will decrease by -63.63% on average per year.
JBGS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.69% yearly.
EPS Next Y-115.16%
EPS Next 2Y-63.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.75%
Revenue Next 2Y1.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBGS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBGS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBGS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.52

4.3 Compensation for Growth

JBGS's earnings are expected to decrease with -63.63% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.63%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.95%, JBGS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.47, JBGS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.26, JBGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.95%

5.2 History

The dividend of JBGS has a limited annual growth rate of 0.08%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)0.08%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

JBGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-51.2%
EPS Next 2Y-63.63%
EPS Next 3YN/A

JBG SMITH PROPERTIES

NYSE:JBGS (9/18/2024, 8:10:01 PM)

After market: 18.39 0 (0%)

18.39

-0.06 (-0.33%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.95%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.81%
ROE -7.41%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.12%
PM (TTM) N/A
GM 50.96%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.26
Quick Ratio 2.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2620%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-115.16%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y0.08%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y